Ana G Rosales

Ms. Ana G Rosales


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2015 in Implementation Science
Verified
Journal Article
Open access
PDF file
ELElizabeth G Liles
Elizabeth G Liles
JSJennifer L. Schneider
Jennifer L. Schneider
AFAdrianne C Feldstein
Adrianne C Feldstein
DMDavid Mosen
David Mosen
NPNancy Perrin
Nancy Perrin
DSDavid H Smith
David H Smith
Few studies describe system-level challenges or facilitators to implementing population-based colorectal cancer (CRC) screening outreach programs. Our qualitative study explored viewpoints of multilevel stakeholders before, during, and after implementation of a centralized outreach program. Program implementation was part of a broader quality-improvement initiative. During 2008–2010, we conducted semi-structured, open-ended individual interviews and focus groups at Kaiser Permanente Northwest (KPNW), a not-for-profit group model health maintenance organization using the practical robust implementation and sustainability model to explore external and internal barriers to CRC screening. We interviewed 55 stakeholders: 8 health plan leaders, 20 primary care providers, 4 program managers, and 23 endoscopy specialists (15 gastroenterologists, 8 general surgeons), and analyzed interview transcripts to identify common as well as divergent opinions expressed by stakeholders. The majority of stakeholders at various levels consistently reported that an automated telephone-reminder system to contact patients and coordinate mailing fecal tests alleviated organizational constraints on staff’s time and resources. Changing to a single-sample fecal immunochemical test (FIT) lessened patient and provider concerns about feasibility and accuracy of fecal testing. The centralized telephonic outreach program did, however, result in some screening duplication and overuse. Higher rates of FIT completion and a higher proportion of positive results with FIT required more colonoscopies. Addressing barriers at multiple levels of a health system by changing the delivery system design to add a centralized outreach program, switching to a more accurate and easier-to-use fecal test, and providing educational and electronic support had both benefits and problematic consequences. Other health care organizations can use our results to understand the complexities of implementing centralized screening programs.

1 August 2014 in Medical Care
Verified
Journal Article
Closed access
AWAmy H. Warriner
Amy H. Warriner
RORyan C. Outman
Ryan C. Outman
AFAdrianne C. Feldstein
Adrianne C. Feldstein
DRDouglas W. Roblin
Douglas W. Roblin
JAJeroan J. Allison
Jeroan J. Allison
KSKenneth Saag
Kenneth Saag
Background: Despite national guidelines recommending bone mineral density screening with dual-energy x-ray absorptiometry (DXA) in women aged 65 years and older, many women do not receive initial screening. Objective: To determine the effectiveness of health system and patient-level interventions designed to increase appropriate DXA testing and osteoporosis treatment through (1) an invitation to self-refer for DXA (self-referral); (2) self-referral plus patient educational materials; and (3) usual care (UC, physician referral). Research Design: Parallel, group-randomized, controlled trials performed at Kaiser Permanente Northwest (KPNW) and Kaiser Permanente Georgia (KPG). Subjects: Women aged 65 years and older without a DXA in past 5 years. Measures: DXA completion rates 90 days after intervention mailing and osteoporosis medication receipt 180 days after initial intervention mailing. Results: From >12,000 eligible women, those randomized to self-referral were significantly more likely to receive a DXA than UC (13.0%–24.1% self-referral vs. 4.9%–5.9% UC, P<0.05). DXA rates did not significantly increase with patient educational materials. Osteoporosis was detected in a greater proportion of self-referral women compared with UC (P<0.001). The number needed to receive an invitation to result in a DXA in KPNW and KPG regions was approximately 5 and 12, respectively. New osteoporosis prescription rates were low (0.8%–3.4%) but significantly greater among self-referral versus UC in KPNW. Conclusions: DXA rates significantly improved with a mailed invitation to schedule a scan without physician referral. Providing women the opportunity to self-refer may be an effective, low-cost strategy to increase access for recommended osteoporosis screening.

1 October 2012
Verified
Journal Article
Closed access
ELElizabeth G. Liles
Elizabeth G. Liles
NPNancy Perrin
Nancy Perrin
ARAna G Rosales
Ana G Rosales
AFAdrianne C. Feldstein
Adrianne C. Feldstein
DSDavid H. Smith
David H. Smith
JSJennifer L. Schneider
Jennifer L. Schneider

2 May 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ELElizabeth G. Liles
Elizabeth G. Liles
NPNancy Perrin
Nancy Perrin
ARAna G Rosales
Ana G Rosales
DSDavid H. Smith
David H. Smith
AFAdrianne C. Feldstein
Adrianne C. Feldstein
TLTheodore R. Levin
Theodore R. Levin
The fecal immunochemical test (FIT) is easier to use and more sensitive than the guaiac fecal occult blood test, but it is unclear how to optimize FIT performance. We compared the sensitivity and specificity for detecting advanced colorectal neoplasia between single-sample (1-FIT) and two-sample (2-FIT) FIT protocols at a range of hemoglobin concentration cutoffs for a positive test. We recruited 2,761 average-risk men and women ages 49-75 referred for colonoscopy within a large nonprofit, group-model health maintenance organization (HMO), and asked them to complete two separate single-sample FITs. We generated receiver-operating characteristic (ROC) curves to compare sensitivity and specificity estimates for 1-FIT and 2-FIT protocols among those who completed both FIT kits and colonoscopy. We similarly compared sensitivity and specificity between hemoglobin concentration cutoffs for a single-sample FIT. Differences in sensitivity and specificity between the 1-FIT and 2-FIT protocols were not statistically significant at any of the pre-specified hemoglobin concentration cutoffs (10, 15, 20, 25, and 30 μg/g). There was a significant difference in test performance of the one-sample FIT between 50 ng/ml (10 μg/g) and each of the higher pre-specified cutoffs. Disease prevalence was low. A two-sample FIT is not superior to a one-sample FIT in detection of advanced adenomas; the one-sample FIT at a hemoglobin concentration cutoff of 50 ng/ml (10 μg/g) is significantly more sensitive for advanced adenomas than at higher cutoffs. These findings apply to a population of younger, average-risk patients in a U.S. integrated care system with high rates of prior screening.

1 April 2013
Verified
Journal Article
Closed access
DMDavid Mosen
David Mosen
AFAdrianne C. Feldstein
Adrianne C. Feldstein
NPNancy Perrin
Nancy Perrin
ARAna G Rosales
Ana G Rosales
DSDavid H. Smith
David H. Smith
JEJennifer Elston-Lafata
Jennifer Elston-Lafata

25 August 2022 in Obesity Research & Clinical Practice
Verified
Journal Article
Closed access
COCaryn Etsuko Shima Oshiro
Caryn Etsuko Shima Oshiro
TFTimothy B. Frankland
Timothy B. Frankland
ARAna G Rosales
Ana G Rosales
THTeresa A. Hillier
Teresa A. Hillier
NPNancy Perrin
Nancy Perrin